First Bancorp’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$113K Hold
539
– – 0.05% 177
2026
Q2
$103K Buy
+539
New +$92.6K 0.04% 193
2022
Q2
– Sell
-1,645
Closed -$215K – 110
2022
Q1
$215K Buy
1,645
+112
+7% +$14.6K 0.2% 99
2021
Q4
$234K Buy
1,533
+38
+3% +$5.88K 0.2% 94
2021
Q3
$242K Buy
+1,495
New +$252K 0.23% 87
2021
Q1
$216K Buy
+1,432
New +$227K 0.21% 97

Other funds holding IBB

First Bancorp's IBB Position: Q3 2026 in Review

First Bancorp held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 539 shares worth $113K. The position accounts for 0.05% of the portfolio, ranked #177.

First Bancorp first reported a position in IBB in Q1 2021 and has held it in 6 quarters since. The position peaked at $242K in Q3 2021. 409 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • First Bancorp held 539 shares of iShares Biotechnology ETF worth $113K as of Q3 2026.
  • First Bancorp left its iShares Biotechnology ETF share count unchanged in Q3 2026.
  • iShares Biotechnology ETF made up 0.05% of First Bancorp's portfolio in Q3 2026, its #177 holding.
  • First Bancorp first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 6 quarters since.
  • First Bancorp's iShares Biotechnology ETF position peaked at $242K in Q3 2021.
  • 409 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on First Bancorp's 13F filing for Q3 2026, filed 26 Oct 2026.